{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:38:23Z","timestamp":1734673103050,"version":"3.32.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,19]]},"DOI":"10.7759\/cureus.76035","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:31:22Z","timestamp":1734665482000},"source":"Crossref","is-referenced-by-count":0,"title":["Carcinoma of Unknown Primary: Integrating Timely Interventions and Molecular Advancements for Improved Outcomes"],"prefix":"10.7759","author":[{"given":"Supriya","family":"Peshin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamtha","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tordjman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaishwarya","family":"Moka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5552","article-title":"Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site","volume":"11","author":"Qaseem A","year":"2019","unstructured":"Qaseem A, Usman N, Jayaraj JS, Janapala RN, Kashif T. Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site. Cureus. 2019, 11:e5552. 10.7759\/cureus.5552","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2004.10.002","article-title":"Cancer of unknown primary (CUP)","volume":"54","author":"Pavlidis N","year":"2005","unstructured":"Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005, 54:243-50. 10.1016\/j.critrevonc.2004.10.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030451","article-title":"Cancer of unknown primary: challenges and progress in clinical management","volume":"13","author":"Laprovitera N","year":"2021","unstructured":"Laprovitera N, Riefolo M, Ambrosini E, Klec C, Pichler M, Ferracin M. Cancer of unknown primary: challenges and progress in clinical management. Cancers (Basel). 2021, 13:451. 10.3390\/cancers13030451","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4050","article-title":"Cancer of unknown primary","volume":"371","author":"Lee MS","year":"2020","unstructured":"Lee MS, Sanoff HK. Cancer of unknown primary. BMJ. 2020, 371:m4050. 10.1136\/bmj.m4050","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0332-2","article-title":"Molecular characterisation and liquid biomarkers in carcinoma of unknown primary (CUP): taking the 'U' out of 'CUP'","volume":"120","author":"Conway AM","year":"2019","unstructured":"Conway AM, Mitchell C, Kilgour E, Brady G, Dive C, Cook N. Molecular characterisation and liquid biomarkers in carcinoma of unknown primary (CUP): taking the 'U' out of 'CUP'. Br J Cancer. 2019, 120:141-53. 10.1038\/s41416-018-0332-2","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2024.10641","article-title":"Tumor-type agnostic, targeted therapies make a new step forward: the first tumor-agnostic approval of a HER2-targeted therapy","volume":"24","author":"Vranic S","year":"2024","unstructured":"Vranic S, Gatalica Z. Tumor-type agnostic, targeted therapies make a new step forward: the first tumor-agnostic approval of a HER2-targeted therapy. Biomol Biomed. 2024, 24:673-5. 10.17305\/bb.2024.10641","journal-title":"Biomol Biomed"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/322014-carcinoma-of-unknown-primary-integrating-timely-interventions-and-molecular-advancements-for-improved-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:31:24Z","timestamp":1734665484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/322014-carcinoma-of-unknown-primary-integrating-timely-interventions-and-molecular-advancements-for-improved-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.76035","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}